InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,658.00
(
0.32%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.18
(
0.27%
)
Bitcoin
62,856.46
(
-0.30%
)
Post# of 3329
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

H2R

Send PM Follow Ignore
Followers 42
Posts 2160
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: lakingsphan0427 post# 3092

Tuesday, 11/07/2017 9:55:29 AM

Tuesday, November 07, 2017 9:55:29 AM

Post# of 3329
Maybe this is what's confusing the market:

Given the potential of the additional Auryxia indication on future prescription demand and the dynamics surrounding Auryxia’s payer mix, prescription demand growth and the resulting net U.S. Auryxia product sales in the third quarter, Keryx is withdrawing its 2017 financial guidance.



Which may sound ominous to some.

Long KERX
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up